Vaccines for prevention of human papillomavirus infection
Foerster V, Murtagh J
Record ID 32006000010
English, French
Authors' objectives:
The aim of this report is to summarize the available information on use of prophylactic human papillomavirus (HPV) vaccines, particularly: Cervarix (GlaxoSmithKline Biologics) and Gardasil (Merck & Co., Inc.).
Authors' recommendations:
Important considerations include vaccine efficacy; acceptability; integration into existing vaccine schedules; cost; role of cervical screening programs; and access, particularly for people in the developing world.
Authors' methods:
Overview
Details
Project Status:
Completed
URL for project:
https://www.ccohta.ca/
Year Published:
2005
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Papillomaviridae
- Cancer Vaccines
- Papillomavirus Infections
Contact
Organisation Name:
Canadian Coordinating Office for Health Technology Assessment
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553, Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Coordinating Office for Health Technology Assessment (CCOHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.